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Abstract
We aimed to obtain insights on the nature of a collection of isolates presumptively identified as atypical Streptococcus
pneumoniae recovered from invasive and non-invasive infections in Spain. One-hundred and thirty-two isolates were
characterized by: optochin susceptibility in ambient and CO2-enriched atmosphere; bile solubility; PCR-based assays
targeting pneumococcal genes lytA, ply, pspA, cpsA, Spn9802, aliB-like ORF2, and a specific 16S rRNA region; multilocus
sequence analysis; and antimicrobial susceptibility. By multilocus sequence analysis, 61 isolates were S. pseudopneumoniae,
34 were pneumococci, 13 were S. mitis, and 24 remained unclassified as non-pneumococci. Among S. pseudopneumoniae
isolates, 51 (83.6%) were collected from respiratory tract samples; eight isolates were obtained from sterile sources. High
frequency of non-susceptibility to penicillin (60.7%) and erythromycin (42.6%) was found. Only 50.8% of the S.
pseudopneumoniae isolates displayed the typical optochin phenotype originally described for this species. None harbored
the cpsA gene or the pneumococcal typical lytA restriction fragment length polymorphism. The Spn9802 and the specific
16S rRNA regions were detected among the majority of the S. pseudopneumoniae isolates (n = 59 and n = 49, respectively).
The ply and pspA genes were rarely found. A high genetic diversity was found and 59 profiles were identified. Among the S.
pneumoniae, 23 were capsulated and 11 were non-typeable. Three non-typeable isolates, associated to international non-
capsulated lineages, were recovered from invasive disease sources. In conclusion, half of the atypical pneumococcal clinical
isolates were, in fact, S. pseudopneumoniae and one-fourth were other streptococci. We identified S. pseudopneumoniae and
non-typeable pneumococci as cause of disease in Spain including invasive disease.
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Introduction
Streptococcus pneumoniae (pneumococcus) is an important human
pathogen worldwide responsible for systemic diseases such as
meningitis, pneumonia, and bacteraemia. [1,2] Culture-based
identification methods usually rely on colony morphology,
optochin susceptibility, bile solubility, and agglutination by the
Quellung reaction. [3] However, exceptions have been described
and include pneumococci that are optochin-resistant, [4,5] bile-
insoluble, [6] and do not have a specific agglutination in the
Quellung reaction due to lack of capsule. [7,8] This latter group is
generally called non-typeable pneumococci and is often found in
colonization. [7,9] Although sporadically, non-typeable pneumo-
cocci have also been associated with disease such as conjunctivitis
(including large outbreaks), [10,11] acute otitis media, [12] acute
exacerbations in patients with chronic obstructive pulmonary
disease (COPD), [13] and more recently in invasive disease. [14].
Pneumococcal isolates displaying odd properties in the assays
described above have been collectively named atypical pneumo-
cocci and are often difficult to identify. On the other hand,
sporadic isolates of closely-related species that have one or more
properties typically associated with pneumococci have been
described. [9,15,16].
In 2004, Arbique and colleagues identified some of these
atypical pneumococci as a new species – Streptococcus pseudopneumo-
niae. [17] Although similar to pneumococci, they were character-
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ized by being bile insoluble and optochin-resistant when incubated
under a 5% CO2 atmosphere but optochin–susceptible when
incubated under ambient atmosphere. S. pseudopneumoniae have
been identified among colonizing children and respiratory
samples. [15,18] Although, their clinical relevance has not been
clearly established, S. pseudopneumoniae have been associated with
COPD, [19] and its disease potential has been demonstrated in
mice models of peritonitis and sepsis. [20].
As biochemical tests are often insufficient to distinguish atypical
S. pneumoniae from S. pseudopneumoniae or other closely related
streptococci several molecular assays have been proposed. The
construction of phylogenetic trees using six concatenated multi-
locus sequence typing (MLST) alleles, called Multilocus Sequence
Analysis (MLSA), is considered a good approach to differentiate S.
pneumoniae from closely related species. [15,21] In addition, several
other assays have been developed most of which are PCR-based
and target specific pneumococcal virulence factors, such as
autolysin A (lytA), pneumolysin (ply), pneumococcal surface protein
A (pspA), or the capsular polysaccharide biosynthesis gene A (cpsA).
[6,15] Unknown putative genes, specific intergenic DNA sequenc-
es, or specific regions of the 16S rRNA, have also been proposed
to be pneumococcal species-specific. [22,23] However, the
occurrence of Streptococcus mitis isolates harbouring genes encoding
S. pneumoniae virulence factors has been reported and whether the
genetic assays recently proposed universally distinguish pneumo-
cocci from the closely related species remains to be seen.
[15,24,25,26,27].
In this study, we aimed to characterize a large collection of
invasive and non-invasive disease isolates obtained in Spain, which
had been identified as atypical pneumococci. We have combined
MLSA with a panel of phenotypic and molecular assays in order to
gain insights on the nature of such isolates.
Materials and Methods
Ethics Statement
This study and publication of the results were approved by the
‘‘Comite´ E`tic d’Investigacio´ Clı´nica del Hospital Universitari de
Bellvitge’’ and written or oral informed consent was considered
not necessary, because data were analyzed anonymously.
Bacterial Isolates
A total of 132 clinical isolates classified as non-(sero)typeable or
atypical pneumococci collected at two Spanish laboratories were
included in the study. There were no duplicates within or between
the two sets studied.
The first set comprised 56 isolates collected at the Spanish
Reference Pneumococcal Laboratory (Centro Nacional de Micro-
biologia, ISCIII, Madrid, Spain), which receives pneumococcal
disease isolates from 190 hospitals throughout the entire country.
The isolates were obtained between 2004 and 2009, and were
mostly (44 out of 56) from non-sterile sites. This set represented
7.7% (56 out of 728) of the total non-(sero)typeable or atypical
pneumococci S. pneumoniae isolated during that period which, in
turn, corresponded to 4.6% of all pneumococcal isolates identified
in the same period. This set included: i) 44 specimens with atypical
pneumococcal identification [optochin resistant in CO2 atmo-
sphere, bile negative, and AccuprobeTM positive (Gen-Probe, San
Diego, California)] of which 43 had been isolated from non-sterile
sites; and ii) 12 non-typeable pneumococci (optochin susceptible in
CO2 atmosphere, and showing no agglutination in the Quellung
reaction), of which eight were invasive isolates.
The second set comprised 76 isolates collected at the tertiary
adult Hospital Universitari de Bellvitge (Barcelona, Spain)
obtained between 1991 and 2009 and were mostly (63 out of 76)
from non-sterile sites. This set represented 43.9% (76 out of 173) of
the total non-(sero)typeable or atypical pneumococci S. pneumoniae
isolated during that period which, in turn, corresponded to 5.1%
of all pneumococcal isolates identified in the same period. This
collection also include two groups of isolates: i) 35 specimens with
atypical pneumococcal identification [reduced optochin suscepti-
bility in CO2 atmosphere, positive SlidexH pneumo-Kit aglutina-
tion test (bioMe´rieux, Marcy-l’Etoile, France)] of which 30 had
been isolated from non-sterile sites; and ii) 41 non-typeable
pneumococci (optochin susceptible in CO2 atmosphere and
showing no agglutination in the Quellung reaction), of which
eight were invasive isolates.
In the total collection invasive isolates were obtained from blood
(n = 11), bronchoalveolar lavage (n = 7), transthoracic needle
aspiration (n = 1), cerebrospinal fluid (n = 1), bronchoscopic-
protected catheter brush (n = 1) and ascitic fluid (n = 1). Non-
invasive isolates were obtained from sputum (n = 75), bronchial
aspiration (n = 23), conjunctiva swab (n = 4), and others (n = 8).
Optochin Susceptibility
Optochin susceptibility was tested by disk diffusion, using
commercially available optochin disks (5 mg; 6 mm; Oxoid,
Hampshire, England) applied onto blood agar plates (trypticase
soy agar supplemented with 5% sheep blood), which had been
inoculated with a 0.5 McFarland standard suspension of the
culture to be tested. Plates (two per isolate) were incubated in
parallel overnight at 37uC in a 5% CO2 and ambient atmosphere
as described by Arbique et al. to differentiate S. pneumoniae from S.
pseudopneumoniae. [17] Isolates were considered to be resistant to
optochin if they displayed inhibition zones smaller than 14 mm.
[17].
Bile Solubility Test
The bile solubility assay was performed according to standard
procedures described by Rouff et al. [3].
Antimicrobial Susceptibility Testing
Antimicrobial susceptibility against penicillin, cefotaxime,
erythromycin, clindamycin, cotrimoxazole, tetracycline, ciproflox-
acin, levofloxacin and chloramphenicol was performed by disk-
diffusion and microdilution method, following the recommenda-
tions and definitions of the Clinical and Laboratory Standards
Institute (CLSI). [28] In particular, for penicillin, pneumococcal
oral penicillin V breakpoints were used (S:#0.06, I:0.12-1, R:$2);
for cefotaxime, pneumococcal meningeal breakpoints were used
(S:#0.5, I:1, R:$2). For ciprofloxacin, an MIC$4 mg/L was
considered resistant.
Capsular Typing
For pneumocccal capsular detection, isolates were serotyped by
the Quellung reaction, and/or by a PCR-based assay following the
protocols described by the CDC. [29,30] Isolates for which a
capsule could not be assigned were probed against Omniserum
(Statens Serum Institute, Copenhagen, Denmark), a serum that
contains antibodies to all known pneumococcal types.
Multiplex PCR for Detection of lytA, cpsA and aliB-like
ORF2
A multiplex PCR assay was used to distinguish S. pneumoniae
from closely related species as previously described. [9] This
multiplex PCR detects internal fragments of cpsA (a conserved
pneumococcal capsular polysaccharide gene); lytA (the major
S. pseudopneumoniae and Non-Typeable Pneumococci
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pneumococcal autolysin); aliB-like ORF2 (a gene described as
frequently present in the capsular region of non-capsulated
pneumococci); [8] and 16S rRNA (positive internal control).
PCR Screening for Additional Putative Specific
Pneumococcal Signatures - pspA, Spn9802 and 16S rRNA
Screening for the presence of pspA (the gene that encodes for the
pneumococcal surface protein A), Spn9802 (a genetic region which
encodes for a protein of unknown function that has initially been
described as a specific target for S. pneumoniae), and a 16S rRNA
allele that has been described as pneumococcal-specific, was done
as described. [22,23,31].
lytA RFLP Signatures
The lytA gene was amplified by PCR and RFLP signatures
characteristic of typical pneumococcal lytA or atypical (non-
pneumococcal) lytA were determined by digesting the amplification
product with BsaAI and separating the fragments by agarose gel
electrophoresis, as published. [16].
ply and mly PCR Detection and RFLP Signatures
The presence of ply (encoding pneumolysin, a cholesterol-
dependent pneumococcal citolysin) or mly (a ply homologue
identified in some S. mitis isolates), [32] was screened by digesting
the amplification product with BsaAI and separating the fragments
by agarose gel electrophoresis, as published. [15].
Multilocus Sequence Typing (MLST)
The amplification of internal fragments of seven housekeeping
genes (aroE, gdh, gki, recP, spi, xpt, and ddl) and allele assignment
were carried out essentially as described in the international
pneumococcal MLST database. [33] Sequencing was performed
at Macrogen, Inc. (Seoul, Korea) and the sequencing analysis was
conducted with DNAStar (Lasergene). For non-pneumococcal
isolates allele assignment was done internally using arbitrary
numbers following the same principles of the published MLST
schemes. The eBURST algorithm [34] was used for determining
the population structure of the S. pseudopneumoniae isolates. Two
strains were considered in the same clonal complex when at least
four of the six alleles were identical (the ddl allele was not
systematically determined for these isolates and was thus excluded
from the analysis). Nucleotide sequences were submitted to the
GenBank database (submission grp 3980184) and are also
available from the corresponding author.
Multilocus Sequence Analysis (MLSA)
Phylogenetic analysis using MLST data was done by concat-
enating the sequences of all MLST loci except ddl to obtain one
single sequence of 2,758 bp. [21] MLST allele sequences of S.
pneumoniae, S. mitis, S. pseudopneumoniae, and S. oralis previously
described were used as controls. [15,35,36,37] Phylogenetic and
molecular evolutionary analyses were conducted using MEGA
version 4 as previously described. [15,38].
Results and Discussion
To obtain insights on the nature and characteristics of 132
Spanish isolates presumptively identified as atypical pneumococci
recovered from invasive and non-invasive disease sources, we
performed several phenotypic and genotypic assays.
For species assignment MLSA was performed as described
previously using the study isolates as well as the collections
previously described by Chi et al. and Simo˜es et al. [15,35] For 22
isolates one or more MLST alleles could not be obtained despite
repeated attempts using various primers and several different
amplification conditions. For this reason, these isolates were not
fully characterized. For the 110 remaining isolates MLSA was
performed and identified 61 isolates as S. pseudopneumoniae, 34 as S.
pneumoniae, and 13 as S. mitis; within the S. pneumoniae branch two
outliers closer to the root of the tree were noted and these
remained unidentified (Figure 1). Isolates which are clearly closely
related to S. pneumoniae but for which species assignment is not
obvious have also been described by others. [39].
Overall, the 22 invasive isolates were identified as 12 S.
pneumoniae, 8 S. pseudopneumoniae, 1 S. mitis, and 1 unidentified
isolate. The 110 non-invasive disease isolates were identified as 53
S. pseudopneumoniae, 22 S. pneumoniae, 12 S. mitis, and 23 unidentified
isolates. In all groups sporadic alleles associated in the MLST
database with typical pneumococci were noted (Table S1). The
phenotypic and genotypic characteristics of each group of isolates
are summarized in Table 1 and are discussed below.
S. pseudopneumoniae
A total of 61 S. pseudopneumoniae were identified by MLSA and
were further analyzed. The clinical sources of the S. pseudopneu-
moniae isolates were: sputum (n = 32), bronchial aspirate (n = 17),
bronchoalveolar lavage (n = 4), blood (n = 2), conjunctiva (n = 2),
nasal swab (n = 1), bronchoscopic-protected catheter brush (n = 1),
pharyngeal swab (n = 1), and ascitic fluid (n = 1). The majority
(88.5%) of the S. pseudopneumoniae were isolated from adults, and
the male gender was predominant (68.9%) (data not shown).
Antimicrobial non-susceptibility rates were high against peni-
cillin (60.7%) and erythromycin (42.6%), as shown in Table 2.
Among the 26 macrolide-resistant isolates, the MLSB phenotype
and the M phenotype were equally distributed. Only nine S.
pseudopneumoniae isolates were fully susceptible to all antimicrobials
tested. High macrolide-resistance rates have been described
among isolates recovered from respiratory samples from New
Zealand, [40] and France. [18] Fluoroquinolone resistant isolates
have also been described. [41] The high antimicrobial resistance
rates together with the confirmation of the ability of this
microorganism to cause invasive diseases raises this pathogen as
a real clinical concern.
The 61 S. pseudopneumoniae isolates displayed heterogeneous
profiles regarding several of the phenotypic and genotypic
characterization assays that were performed (Table 1). In
particular, 16.4% of the isolates were susceptible to optochin in
a 5%CO2-enriched atmosphere and 63.9% were susceptible in
ambient atmosphere. Only 50.8% of the S. pseudopneumoniae isolates
displayed the typical phenotype originally described for this species
(optochin-resistant in CO2 but susceptible in O2 atmosphere).
Also, 36.1% of the isolates were bile soluble. Although these
biochemical traditional identification tests are the first step for
phenotypic identification of S. pseudopneumoniae, in the present study
we observed that these characteristics were frequently diverse
among the isolates of this species, as previously shown. [42].
Screening for genetic markers described by others as species-
specific for S. pneumoniae – specific 16S-rRNA, Spn9802, pspA and
ply - revealed their presence in some S. pseudopneumoniae isolates in
contrast with previous publications. [22,23,43] No S. pseudopneu-
moniae isolates harbored the pneumococcal lytA nor the cpsA
capsular gene. The aliB-like ORF2 was present in all isolates. The
lack of cpsA was in line with previous observations that suggest S.
pseudopneumoniae lacks a pneumococcus-like capsule. [44].
A high clonal diversity was found as 59 allelic profiles were
detected by MLST (Figure 2 and Table S1). By e-BURST seven
clonal groups were identified and each contained only two allelic
S. pseudopneumoniae and Non-Typeable Pneumococci
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profiles. On two occasions, pairs of isolates were found to have the
same allelic profile. No association between isolates sharing a same
allelic profile or being in the same clonal group was obvious.
S. pneumoniae
Out of 34 S. pneumoniae identified in this collection, 23 isolates
previously identified as non-(sero)typeable pneumococci were in
fact capsulated when reanalyzed; the other 11 were confirmed as
non-typeable. Several explanations could be put forward to justify
why isolates previously identified as atypical pneumococcal were
found to be capsulated upon reanalysis. For example, differences
in the quality of the antisera, lack of capsular production due to
passage of isolates on agar plates, and human error.
The clinical sources of the capsulated isolates were sputum
(n = 14), bronchoalveolar lavage (n = 2), blood (n = 5), transtho-
racic needle aspiration (n = 1), and umbilical swab (n = 1). The
majority were isolated from adults (87.5%), and the male gender
was predominant (75.0%). The clinical sources of the non-
capsulated isolates were blood (n = 4), sputum (n = 4), conjunctival
Figure 1. Genetic relationships of the strains determined by MLSA. The symbols indicate: grey triangle, non-invasive disease strains; black
circle, invasive disease strains; white square, strains described in other studies. [15,17,35,36,37].
doi:10.1371/journal.pone.0057047.g001
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swab (n = 2), and nasal swab (n = 1). The majority (90%) were
isolated from adults, and 40% were males (data not shown).
Among the capsulated isolates, the most frequent serotypes were
38 and 6B (3 isolates each, Table 3). Interestingly, these serotypes
were also frequently misidentified as atypical pneumococci in a
recent study from the USA. [45] This observation may indicate
that some representatives of these serotypes may be hard to
visualize by the Quellung reaction, leading to misidentification, or
that these serotypes may contain unknown different subtypes.
Multiresistance (non-susceptibility to three or more classes of
antimicrobials) was found among 11 isolates (3 were from invasive
disease) and was associated to NT (n = 4), and serotypes 6B (n = 3),
19F (n = 2), 19A (n = 1), and 33F (n = 1) (Table 3). Three of the
eleven NT isolates were multiresistant. A high frequency of
multiresistance among non-typeable strains has been observed in
other studies. [7,9].
Regarding the classical presumptive identification of pneumo-
cocci based on optochin susceptibility in CO2 atmosphere and bile
solubility, many exceptions were found among this group of
isolates: 20 were optochin resistant and one was bile insoluble.
Although rare, these exceptional phenotypes were previously
reported in other studies. [46].
Table 1. Phenotypic and genotypic characterization of MLSA typeable isolates.
MLSA classification (%)
S. pseudopneumoniae (n = 61) S. pneumonia S. mitis (n = 13)
typeable (n = 23) nontypeable (n = 11)
Phenotypic characterization
optochin susceptibility ($14 mm)
5% CO2 10 (16.4) 8 (34.8) 6 (54.6) 4 (30.8)
ambient atmosphere 39a (63.9) 21 (91.3) 6b (54.6) 8c (61.5)
bile solubility 22 (36.1) 22 (95.7) 11 (100) 2 (15.4)
Genotypic characterization
PCR-based
pneumococcal lytA 0 (0) 23 (100) 11 (100) 0 (0)
pneumococcal specific 16S-rRNA 49 (80.3) 23 (100) 11 (100) 2 (15.4)
Spn9802 59 (96.7) 23 (100) 8 (72.7) 8 (61.5)
pspA 1 (1.6) 21 (91.3) 10 (90.9) 7 (53.8)
cpsA 0 (0.0) 17 (73.9) 2 (18.2) 0 (0)
aliB-like ORF2 61 (100.0) 7 (30.4) 9 (81.8) 12 (92.3)
RFLP signatures
pneumococcal lytA/atypical lytA 0 (0)/61 (100) 23 (100) 9 (81.8)/2 (18.2) 0/11(84.6)d
ply/mly 7 (11.5)/54 (88.5) 23 (100)/0 (0) 11 (100)/0 2 (15.4)/7 (53.8)e
a11 strains did not grow in an ambient atmosphere, among the 39 isolates susceptible to optochin in ambient atmosphere, 31 were resistant in CO2.
b3 strains did not grow in ambient atmosphere.
c2 strains did not grow in ambient atmosphere.
d2 strains were not screened.
e2 strains did not amplify, 2 yielded a mixed pattern.
doi:10.1371/journal.pone.0057047.t001
Table 2. Antimicrobial susceptibility of 61 S. pseudopneumoniae clinical isolates.
Antibiotic MIC (mg/L) No. non-susceptible isolates (%)
Range MIC50 MIC90
Penicillin #0.03–2 #0.03 0.5 37 (60.7%)
Cefotaxime #0.03–1 #0.12 0.25 2 (3.3%)
Erythromycin #0.12–$128 #0.12 $32 26 (42.6%)
Clindamycin #0.12–$128 #0.12 $0.5 13 (21.3%)
Cotrimoxazole #0.5/9.5–$2/38 #0.5/9.5 $2/38 24 (39.3%)
Tetracycline #0.12–64 #0.25 4 18 (29.5%)
Ciprofloxacin #0.12–32 #1 #1 6 (9.8%)
Levofloxacin #0.12–$16 #1 #1 3 (4.9%)
Chloramphenicol #2–4 #2 #2 0 (0%)
doi:10.1371/journal.pone.0057047.t002
S. pseudopneumoniae and Non-Typeable Pneumococci
PLOS ONE | www.plosone.org 5 February 2013 | Volume 8 | Issue 2 | e57047
Genotypic analysis showed the ubiquitous presence of pneu-
mococcal lytA, specific16S-rRNA, and ply. Spn9802 was present in
all but three non-typeable isolates contrasting with previous
publications that suggested that this ORF was ubiquitous in
pneumococcus. [22,23].
The lytA-typical pneumococcal RFLP signature was identified in
all but two isolates. The two exceptions were associated with a
novel signature also distinct from the characteristic atypical
pattern associated with non-pneumococcal isolates. The molecular
basis of this novel signature is currently being investigated.
The capsular gene cpsA was present in most capsulated isolates
with the exception of those of serotypes 25A and 38 in agreement
with published literature. [9,47] Instead, isolates of serotype 25A
and 38 had aliB-likeORF2 as described, [9] which was also
detected in single isolates of serotype 35A. Among non-typeable
isolates, nine had aliB-like ORF2 and two had cpsA. A possible
explanation for this latter observation is that the isolates may have
lost the capacity to produce a capsule in vitro [14] due to alterations
in the capsular genes. [48].
MLST analysis of the S. pneumoniae isolates showed that close to
one-third (32.4%) had novel allelic profiles. Of interest, six of the
nine allelic profiles identified among the non-typeable pneumo-
coccal isolates were previously identified in other countries and
were also associated to non-serotypeability. The international
PMEN lineages USANT-ST448 and NorwayNT-ST344 accounted
for five isolates, three having been recovered from invasive disease.
Non-typeable pneumococci were previously found not only among
colonization, but also as causative agents of acute otitis media and
conjunctivitis. [7,9,11,12,14] The association of MLST lineages
exclusive of non-capsulated isolates to invasive disease has only
been described recently. [14] These observations suggest that, in
spite of their sporadic occurrence, non-typeable pneumococci
have a higher clinical impact than previously thought as they have
been associated with a varied spectrum of infections including
invasive disease.
S. mitis
Although the 13 S. mitis isolates were phenotypically and
genotypically heterogeneous, lytA analyses (in addition to MLSA)
consistently suggested they were not pneumococci. Of interest, and
as observed for some S. pseudopneumoniae isolates, a few of the S. mitis
harboured genetic markers – Spn9802, pspA and ply - previously
associated to pneumococci. The occurrence of S. mitis isolates
harbouring genes encoding S. pneumoniae virulence factors has been
described, [15,26] and led to the suggestion that identification of
this group of bacteria by a single identification marker may not be
possible as horizontal gene transfer between them can occur.
[24,27].
Regarding antimicrobial susceptibility, 84.6% were non-suscep-
tible to penicilin and 69.2% were multidrug resistant. Most of the
isolates (12/13) were recovered from non-invasive disease;
however, one isolate was recovered from bronchoalveolar lavage.
S. mitis isolates have been previously associated with disease,
[36,49,50] and high levels of antimicrobial resistance. [15,51].
Non-classified Isolates
Close to one-fifth of the isolates (18.2%) remained non-
classified. Although MLSA associated to the MLST S. pneumoniae
scheme works well to identify atypical isolates, we were unable to
apply it to 24 isolates due to lack of amplification of some DNA
fragments with the combinations of primers that are routinely used
for S. pneumoniae. For these isolates, alternative primers, MLSA
schemes or assays would have been needed. [52] Of note, only one
isolate was recovered from invasive disease.
Figure 2. Representation of the S. pseudopneumoniae population by eBURST analysis. Each point represents a different allele combination.
Solid lines, single-locus variants; dashed circles, invasive disease isolates; larger circles indicate two isolates with the same allele combination.
doi:10.1371/journal.pone.0057047.g002
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Conclusions
In summary, among disease isolates classified as atypical
pneumococci, close to half (46.2%) were S. pseudopneumoniae, and
only a quarter were pneumococci (17.4% were capsulated and
8.3% were non-typeable). In addition, 9.8% were S. mitis and the
rest were non-pneumococci that remained unidentified. In
agreement with other studies, we found that many of the currently
proposed methodologies to distinguish pneumococci from closely-
related species are not species-specific. Furthermore, S. pseudopneu-
moniae that failed to have the optochin phenotypes described by
Arbique et al. were also identified.
We found that S. pseudopneumoniae have low clonality and that
antimicrobial resistance is well-disseminated is this species. Our
study stresses the clinical role of S. pseudopneumoniae and non-
typeable pneumococci since they have the capacity to cause
invasive disease and the high antimicrobial resistance rates are of
concern.
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divergent from all the alleles described at the S. pneumoniae MLST
database as of July 26, 2012. The allele number of the closest
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Table 3. Properties of S. pneumoniae clinical isolates.
Serotypes
Sequence typea
(no. of isolates) MLST allelic profile Antimicrobial non-susceptibility patternb Observationsc
6B 90 (1) 5-6-1-2-6-3-4 PEN, TET, ERY, CLI, CTX Spain6B-ST90
94 (1) 5-6-1-2-6-3-54 PEN, TET, CHL, ERY, CLI, SXT, CIP Spain6B-ST90 SLV
8270 (1) 32-28-1-1-15-52-15 TET, ERY, CLI
38 393 (2) 10-43-41-18-13-49-6 Susceptible
8278 (1) 10-61-41-18-13-49-6 Susceptible
13 70 (1) 2-13-1-4-6-12-1 Susceptible
8271 (1) 7-13-368-4-6-1-20 Susceptible
19F 89 (1) 5-5-7-7-8-5-1 PEN, TET, CHL, SXT
8275 (1) 5-5-7-7-8-5-538 PEN, TET, CHL, ERY, CLI, CTX, SXT
25A 393 (1) 10-43-41-18-13-49-6 Susceptible
8274 (1) 10-43-41-18-13-37-6 PEN, SXT
3 180 (1) 7-15-2-10-6-1-22 Susceptible Netherlands3-ST180
4 247 (1) 16-13-4-5-6-10-14 Susceptible
7F 2178 (1) 10-20-14-1-6-20-29 TET Denmark12F-ST218 SLV
10A 8272 (1) 5-13-4-4-6-1-20 Susceptible
17A 8277 (1) 5-365-2-16-6-3-245 Susceptible
18C 191 (1) 8-9-2-1-6-1-17 Susceptible Netherlands7F-ST191
19A 81 (1) 4-4-2-4-4-1-1 PEN, TET, CHL, ERY, CLI, CTX, SXT, CIP, LEV Spain23F-ST81
20 8269 (1) 15-364-8-18-15-1-31 Susceptible
22F 2104 (1) 2-16-1-4-6-1-1 Susceptible
33F 1012 (1) 2-5-29-18-42-3-18 TET, ERY, CLI
35A 1273 (1) 10-12-4-12-9-28-18 Susceptible
NT 448 (2) 8-5-2-27-2-11-71 Susceptible USANT-ST448
508 (2) 13-8-65-1-60-16-6 Susceptible
66 (1) 2-8-2-4-6-1-1 PEN, TET, SXT, CIP, LEV
72 (1) 2-13-2-4-9-4-1 Susceptible
344 (1) 8-37-9-29-2-12-53 PEN, TET, ERY, SXT NorwayNT-ST344
942 (1) 8-10-15-27-2-28-4 PEN, SXT
8268 (1) 8-10-84-1-2-14-4 Susceptible
8273 (1) 8-37-2-27-2-11-53 Susceptible USANT-ST448 DLV
8276 (1) 8-178-9-29-2-12-15 PEN, TET, ERY, CLI, SXT NorwayNT-ST344 DLV
aNovel STs and alleles found in this study are represented in bold.
bPEN, penicillin; CTX, cefotaxime; ERY, erythromycin; CLI, clindamycin; TET, tetracycline; CHL, chloramphenicol, SXT, trimethoprim-sulfamethoxazole non-susceptible;
CIP, ciprofloxacin; LEV, levofloxacin.
cInternational clones of PMEN; SLV, Single Locus Variant; DLV, Double Locus Variant.
doi:10.1371/journal.pone.0057047.t003
S. pseudopneumoniae and Non-Typeable Pneumococci
PLOS ONE | www.plosone.org 7 February 2013 | Volume 8 | Issue 2 | e57047
Acknowledgments
We would like to acknowledge the use of the pneumococcal MLST
database, which is located at Imperial College London and is funded by the
Wellcome Trust.
Author Contributions
Revised the manuscript and approved the final version: RSL DR ASS AD
AF JL HL CA. Conceived and designed the experiments: DR ASS JL CA
RSL. Performed the experiments: DR ASS AD. Analyzed the data: DR
ASS AD CA RSL. Contributed reagents/materials/analysis tools: AF JL
HL CA RSL. Wrote the paper: DR ASS RSL.
References
1. Blasi F, Mantero M, Santus P, Tarsia P (2012) Understanding the burden of
pneumococcal disease in adults. Clin Microbiol Infect 18 Suppl 5: 7–14.
2. O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009)
Burden of disease caused by Streptococcus pneumoniae in children younger than 5
years: global estimates. Lancet 374: 893–902.
3. Ruoff KL, Whiley RA, Beighton D (2003) Streptococcus. In: Murray PR, Baron
EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical
microbiology. 8th edition ed. Washington D.C.: ASM Press.
4. Mun˜oz R, Fenoll A, Vicioso D, Casal J (1990) Optochin-resistant variants of
Streptococcus pneumoniae. Diagn Microbiol Infect Dis 13: 63–66.
5. Nunes S, Sa´-Lea˜o R, de Lencastre H (2008) Optochin resistance among
Streptococcus pneumoniae strains colonizing healthy children in Portugal. J Clin
Microbiol 46: 321–324.
6. Obregon V, Garcı´a P, Garcı´a E, Fenoll A, Lopez R, et al. (2002) Molecular
peculiarities of the lytA gene isolated from clinical pneumococcal strains that are
bile insoluble. J Clin Microbiol 40: 2545–2554.
7. Sa´-Lea˜o R, Simo˜es AS, Nunes S, Sousa NG, Fraza˜o N, et al. (2006)
Identification, prevalence and population structure of non-typable Streptococcus
pneumoniae in carriage samples isolated from preschoolers attending day-care
centres. Microbiology 152: 367–376.
8. Hathaway LJ, Stutzmann Meier P, Battig P, Aebi S, Muhlemann K (2004) A
homologue of aliB is found in the capsule region of nonencapsulated Streptococcus
pneumoniae. J Bacteriol 186: 3721–3729.
9. Simo˜es AS, Valente C, de Lencastre H, Sa´-Lea˜o R (2011) Rapid identification of
noncapsulated Streptococcus pneumoniae in nasopharyngeal samples allowing
detection of co-colonization and reevaluation of prevalence. Diagn Microbiol
Infect Dis 71: 208–216.
10. Berron S, Fenoll A, Ortega M, Arellano N, Casal J (2005) Analysis of the genetic
structure of nontypeable pneumococcal strains isolated from conjunctiva. J Clin
Microbiol 43: 1694–1698.
11. Martin M, Turco JH, Zegans ME, Facklam RR, Sodha S, et al. (2003) An
outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med
348: 1112–1121.
12. Xu Q, Kaur R, Casey JR, Sabharwal V, Pelton S, et al. (2011) Nontypeable
Streptococcus pneumoniae as an otopathogen. Diagn Microbiol Infect Dis 69: 200–
204.
13. Domenech A, Ardanuy C, Calatayud L, Santos S, Tubau F, et al. (2011)
Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute
exacerbations in patients with chronic obstructive pulmonary disease.
J Antimicrob Chemother 66: 487–493.
14. Scott JR, Hinds J, Gould KA, Millar EV, Reid R, et al. (2012) Nontypeable
pneumococcal isolates among navajo and white mountain apache communities:
are these really a cause of invasive disease? J Infect Dis 206: 73–80.
15. Simo˜es AS, Sa´-Lea˜o R, Eleveld MJ, Tavares DA, Carric¸o JA, et al. (2010)
Highly penicillin-resistant multidrug-resistant pneumococcus-like strains colo-
nizing children in Oeiras, Portugal: genomic characteristics and implications for
surveillance. J Clin Microbiol 48: 238–246.
16. Llull D, Lopez R, Garcia E (2006) Characteristic signatures of the lytA gene
provide a basis for rapid and reliable diagnosis of Streptococcus pneumoniae
infections. J Clin Microbiol 44: 1250–1256.
17. Arbique JC, Poyart C, Trieu-Cuot P, Quesne G, Carvalho Mda G, et al. (2004)
Accuracy of phenotypic and genotypic testing for identification of Streptococcus
pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J Clin
Microbiol 42: 4686–4696.
18. Laurens C, Michon AL, Marchandin H, Bayette J, Didelot MN, et al. (2012)
Clinical and antimicrobial susceptibility data of 140 Streptococcus pseudopneumoniae
isolates in France. Antimicrob Agents Chemother 56: 4504–4507.
19. Keith ER, Murdoch DR (2008) Antimicrobial susceptibility profile of Streptococcus
pseudopneumoniae isolated from sputum. Antimicrob Agents Chemother 52: 2998.
20. Harf-Monteil C, Granello C, Le Brun C, Monteil H, Riegel P (2006) Incidence
and pathogenic effect of Streptococcus pseudopneumoniae. J Clin Microbiol 44: 2240–
2241.
21. Hanage WP, Kaijalainen T, Herva E, Saukkoriipi A, Syrjanen R, et al. (2005)
Using multilocus sequence data to define the pneumococcus. J Bacteriol 187:
6223–6230.
22. El Aila NA, Emler S, Kaijalainen T, De Baere T, Saerens B, et al. (2010) The
development of a 16S rRNA gene based PCR for the identification of
Streptococcus pneumoniae and comparison with four other species specific PCR
assays. BMC Infect Dis 10: 104.
23. Suzuki N, Seki M, Nakano Y, Kiyoura Y, Maeno M, et al. (2005) Discrimination
of Streptococcus pneumoniae from viridans group streptococci by genomic subtractive
hybridization. J Clin Microbiol 43: 4528–4534.
24. Kilian M, Poulsen K, Blomqvist T, Havarstein LS, Bek-Thomsen M, et al.
(2008) Evolution of Streptococcus pneumoniae and its close commensal relatives.
PLoS One 3: e2683.
25. Denapaite D, Bruckner R, Nuhn M, Reichmann P, Henrich B, et al. (2010) The
genome of Streptococcus mitis B6–what is a commensal? PLoS One 5: e9426.
26. Johnston C, Hinds J, Smith A, van der Linden M, Van Eldere J, et al. (2010)
Detection of large numbers of pneumococcal virulence genes in streptococci of
the mitis group. J Clin Microbiol 48: 2762–2769.
27. Whatmore AM, Efstratiou A, Pickerill AP, Broughton K, Woodard G, et al.
(2000) Genetic relationships between clinical isolates of Streptococcus pneumoniae,
Streptococcus oralis, and Streptococcus mitis: characterization of ‘‘Atypical’’ pneumo-
cocci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-
encoding genes. Infect Immun 68: 1374–1382.
28. Clinical and Laboratory Standards Institute (2008) Performance standards for
antimicrobial susceptibility testing; 18th informational supplement. CLSI
document M100-S18. Wayne, PA.
29. Pai R, Gertz RE, Beall B (2006) Sequential multiplex PCR approach for
determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin
Microbiol 44: 124–131.
30. Available: http://www.cdc.gov/ncidod/biotech/strep/pcr.htm.Accessed 2012
November 5.
31. Rolo D, Ardanuy C, Fleites A, Martı´n R, Lin˜ares J (2009) Diversity of
pneumococcal surface protein A (PspA) among prevalent clones in Spain. BMC
Microbiol 9: 80.
32. Jefferies JM, Johnston CH, Kirkham LA, Cowan GJ, Ross KS, et al. (2007)
Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae
associated with disease outbreaks. J Infect Dis 196: 936–944.
33. Available: http://spneumoniae.mlst.net/.Accessed 2012 November 5.
34. Available: http://eburst.mlst.net/.Accessed 2012 November 5.
35. Chi F, Nolte O, Bergmann C, Ip M, Hakenbeck R (2007) Crossing the barrier:
evolution and spread of a major class of mosaic pbp2x in Streptococcus pneumoniae,
S. mitis and S. oralis. Int J Med Microbiol 297: 503–512.
36. Balsalobre L, Hernandez-Madrid A, Llull D, Martin-Galiano AJ, Garcia E, et al.
(2006) Molecular characterization of disease-associated streptococci of the mitis
group that are optochin susceptible. J Clin Microbiol 44: 4163–4171.
37. Shahinas D, Tamber GS, Arya G, Wong A, Lau R, et al. (2011) Whole-genome
sequence of Streptococcus pseudopneumoniae isolate IS7493. J Bacteriol 193: 6102–
6103.
38. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary
Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596–1599.
39. Scholz CF, Poulsen K, Kilian M (2012) Novel molecular method for
identification of Streptococcus pneumoniae applicable to clinical microbiology and
16S rRNA sequence-based microbiome studies. J Clin Microbiol 50: 1968–
1973.
40. Keith ER, Podmore RG, Anderson TP, Murdoch DR (2006) Characteristics of
Streptococcus pseudopneumoniae isolated from purulent sputum samples. J Clin
Microbiol 44: 923–927.
41. Balsalobre L, Ortega M, de la Campa AG (2012) Characterization of
recombinant fluoroquinolone-resistant pneumococcus-like isolates. Antimicrob
Agents Chemother.
42. Wessels E, Schelfaut JJ, Bernards AT, Claas EC (2012) Evaluation of several
biochemical and molecular techniques for identification of Streptococcus pneumoniae
and Streptococcus pseudopneumoniae and their detection in respiratory samples. J Clin
Microbiol 50: 1171–1177.
43. Abdeldaim G, Herrmann B, Molling P, Holmberg H, Blomberg J, et al. (2010)
Usefulness of real-time PCR for lytA, ply, and Spn9802 on plasma samples for the
diagnosis of pneumococcal pneumonia. Clin Microbiol Infect 16: 1135–1141.
44. Park HK, Lee SJ, Yoon JW, Shin JW, Shin HS, et al. (2010) Identification of the
cpsA gene as a specific marker for the discrimination of Streptococcus pneumoniae
from viridans group streptococci. J Med Microbiol 59: 1146–1152.
45. Ing J, Mason EO, Kaplan SL, Lamberth LB, Revell PA, et al. (2012)
Characterization of nontypeable and atypical Streptococcus pneumoniae pediatric
isolates from 1994 to 2010. J Clin Microbiol 50: 1326–1330.
46. Fenoll A, Mun˜oz R, Garcia E, de la Campa AG (1994) Molecular basis of the
optochin-sensitive phenotype of pneumococcus: characterization of the genes
encoding the F0 complex of the Streptococcus pneumoniae and Streptococcus oralis H(+)-
ATPases. Mol Microbiol 12: 587–598.
47. Bentley SD, Aanensen DM, Mavroidi A, Saunders D, Rabbinowitsch E, et al.
(2006) Genetic analysis of the capsular biosynthetic locus from all 90
pneumococcal serotypes. PLoS Genet 2: e31.
48. Melchiorre S, Camilli R, Pietrantoni A, Moschioni M, Berti F, et al. (2012) Point
mutations in wchA are responsible for the non-typability of two invasive
Streptococcus pneumoniae isolates. Microbiology 158: 338–344.
S. pseudopneumoniae and Non-Typeable Pneumococci
PLOS ONE | www.plosone.org 8 February 2013 | Volume 8 | Issue 2 | e57047
49. Leegaard TM, Bootsma HJ, Caugant DA, Eleveld MJ, Mannsaker T, et al.
(2010) Phenotypic and genomic characterization of pneumococcus-like strepto-
cocci isolated from HIV-seropositive patients. Microbiology 156: 838–848.
50. Douglas CW, Heath J, Hampton KK, Preston FE (1993) Identity of viridans
streptococci isolated from cases of infective endocarditis. J Med Microbiol 39:
179–182.
51. Ioannidou S, Tassios PT, Kotsovili-Tseleni A, Foustoukou M, Legakis NJ, et al.
(2001) Antibiotic resistance rates and macrolide resistance phenotypes of viridans
group streptococci from the oropharynx of healthy Greek children.
Int J Antimicrob Agents 17: 195–201.
52. Bishop CJ, Aanensen DM, Jordan GE, Kilian M, Hanage WP, et al. (2009)
Assigning strains to bacterial species via the internet. BMC Biol 7: 3.
S. pseudopneumoniae and Non-Typeable Pneumococci
PLOS ONE | www.plosone.org 9 February 2013 | Volume 8 | Issue 2 | e57047
